#159: Multiple Sclerosis in Saudi Arabia. Care, Treatment, Research, and Public Awareness

Mosque courtyard in Saudi Arabia with a tall minaret, wide tiled square, and people walking under a bright blue sky

Multiple sclerosis in Saudi Arabia is gaining increasing attention as awareness, treatment options, and research continue to evolve. In this interview, Dr. Yasser Alamri shares valuable insights into the current state of MS care, the challenges patients face, and why early treatment can change the course of the disease.

You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Table of Contents

Introduction – Getting to Know You

Who are you and what led you to neurology and MS?

Dr. Yasser Alamri, Neurology Consultant and Multiple Sclerosis Specialist:
I never initially planned to specialize in neurology. Like many medical students, I thought it was one of the most challenging fields. But over time, I became curious and accepted the challenge.

During my residency, I originally focused on stroke and neurointervention. However, in my final year, I noticed a growing number of patients with multiple sclerosis who were already experiencing significant disability. I felt that this should not be the natural course of the disease.

That realization motivated me to specialize in MS care, where I saw a real unmet need and an opportunity to improve patients’ lives.

Portrait of a man with a short beard wearing a white traditional Saudi garment and a red-and-white checkered headscarf, looking directly at the camera with a neutral expression against a plain light background.

MS in Saudi Arabia – Numbers and Historical Context

How many people are living with MS in Saudi Arabia?

Dr. Alamri:
According to a 2018 study, around 13,000 people were diagnosed with MS in Saudi Arabia. However, this number likely underestimates the true prevalence.

Not all hospitals participated in the study, and diagnostic criteria have improved significantly since then. With better access to MRI (magnetic resonance imaging) and increased awareness, we are identifying more cases today.

How has awareness evolved over time?

Dr. Alamri:
There are two key aspects: healthcare professionals and the general public.

On the medical side, we now understand that early use of high-efficacy therapies can prevent long-term disability. In the past, treatment approaches were more conservative.

Among the public, awareness has improved significantly. Previously, many symptoms were dismissed as vitamin deficiencies or stress. Today, patients are more informed and actively seek medical care.

MS societies in Saudi Arabia have also played a major role in spreading awareness and supporting patients.

Access to Care and Neurology Services

How available are MS specialists?

Dr. Alamri:
In the past, there were very few MS specialists. Today, we have over 55 specialists across the country.

Most major cities now have at least two MS neurologists. While access is generally good, some regions—especially in the north—are still underserved.

What about other healthcare professionals?

Dr. Alamri:
MS care requires a multidisciplinary approach. It’s not just neurologists—it involves nurses, general practitioners, psychologists, and therapists.

We are still improving coordination in these areas, especially in MS nursing and integrated care models.

Urban vs. rural care differences

Dr. Alamri:
Saudi Arabia has fewer “rural” structures compared to other countries, but there are still differences between large and smaller cities.

Access to medication is consistent nationwide, which is a major strength. However, some patients find it difficult to travel for specialist care.

Treatment Approach and Disease-Modifying Therapies

What is the current treatment approach?

Dr. Alamri:
One of the biggest advantages in Saudi Arabia is access. Almost all MS therapies are available, and most patients receive treatment through the governmental healthcare system—free of charge.

This allows us to start treatment early and adjust or switch therapies quickly when needed.

Therapy switching – is it easy?

Dr. Alamri:
Yes, switching therapies is generally straightforward. In many cases, we transition patients to higher-efficacy treatments within one to two months.

This flexibility is crucial for optimizing outcomes.

Public Awareness, Stigma, and Social Perception

How is MS perceived in society?

Dr. Alamri:
Awareness has improved, but misconceptions still exist. Some people believe MS always leads to severe disability or wheelchair dependence.

These beliefs can have a strong psychological impact on patients.

How do you address stigma?

Dr. Alamri:
Education is key. I provide patients with trusted resources and encourage them to avoid misinformation online.

We also introduced a multidisciplinary program where newly diagnosed patients receive immediate support from:

  • Clinical psychologists
  • Dietitians

This helps patients process their diagnosis and avoid harmful misconceptions.

Do stigmas affect daily life?

Dr. Alamri:
There can be concerns around employment or social roles, but overall, regulations in Saudi Arabia protect people with chronic illnesses.

Stigma still exists, but it is decreasing with growing awareness.

Rehabilitation and Living with MS

What role does rehabilitation play?

Dr. Alamri:
Rehabilitation is essential but often underestimated. It includes:

  • Physiotherapy
  • Occupational therapy
  • Speech therapy
  • Cognitive training

These services are available across the country, especially in larger cities.

Is access equal nationwide?

Dr. Alamri:
Access exists everywhere, but specialized services are more developed in major cities.

Tele-rehabilitation is not widely implemented yet, but it could be an important future step.

Research and International Collaboration

What is the current state of MS research?

Dr. Alamri:
There is strong interest in MS research, particularly in university and major governmental hospitals.

However, we still need:

  • Larger data registries
  • Stronger multicenter collaboration

Some regions have already started building local registries.

How important is international collaboration?

Dr. Alamri:
It is extremely important. Collaborating with international experts helps us improve treatment strategies and avoid complications like over-immunosuppression.

We are moving toward more personalized treatment approaches—also known as precision medicine.

Quickfire Q&A Session

Complete the sentence: "For me, multiple sclerosis is...."

Dr. Alamri: “Where timing defines the future.”

What development would you like to see in the next 5 years?

Dr. Alamri: Early diagnosis and early treatment for every patient.

Farewell and Outlook

What message would you like to share?

Dr. Alamri:
MS today is very different from the past. We now have effective treatments, better understanding, and improved long-term outcomes.

Do not delay evaluation. Do not fear treatment. Early care truly makes a difference.

Where can people follow your work?

Dr. Alamri:
I share updates mainly on the platform X (formerly Twitter) and occasionally on TikTok, focusing on education and awareness.

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

* This text contains affiliate links. This means that I get a small compensation if you buy the product recommended by me through the link. For you nothing changes in the price of the product. And it helps me to pay for the blog and to write new posts.

Teile diesen Beitrag

Ähnliche Beiträge

Portraitbild Nele Handwerker

Nele von Horsten

Blogger & Patient Advocate

I show you how to make the best of your life with MS from family to career to hobbies. Thanks to science and research, a lot is possible nowadays.

Nele von Horsten

Newsletter

Do you want to understand MS better?

Then get 11 impulses for a positive course as a gift and receive important information about the disease.

My favorites
Explore

Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.

Wait a moment!

Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.